Dow Down 0.17% Nasdaq Down 0.28%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NasdaqCM
2.67 Sep 30, 4:00PM EDT
Prev Close:2.67
Open:N/A
Bid:0.27 x 100
Ask:2.78 x 100
1y Target Est:8.04
Beta:1.24
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:N/A - N/A
52wk Range:2.63 - 14.25
Volume:0
Avg Vol (3m):152,356
Market Cap:56.44M
P/E (ttm):N/A
EPS (ttm):-2.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OGXI

Comparison

Symbol% ChgMkt Cap
OGXI 0.00%56.44M
BMY84.25B
CELG75.78B
PFE187.50B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.68
Quarterly EPS Est (Sep-14) :-0.37
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback